Lee Jack, Tomkins Maria, McDonald Darran, Martin-Grace Julie, Carthy Claire, Finnegan John, Mulholland Douglas, Dugal Neal, Hill Arnold D K, O'Reilly Michael W, Sherlock Mark
Endocrinol Diabetes Metab Case Rep. 2025 Feb 21;2025(1). doi: 10.1530/EDM-24-0137. Print 2025 Jan 1.
We describe a case of a 42-year-old gentleman, 5 years post-transsphenoidal surgery (TSS) for pituitary-dependent Cushing's disease, initially presenting with malignant hypertension. Despite an initial improvement in his blood pressure post-TSS, he was found to be persistently hypertensive on follow-up despite no clinical or biochemical evidence of recurrence of hypercortisolism. His blood pressure remained elevated despite five antihypertensive agents. His renin concentration was <5 mIU/L (9-103.5) and aldosterone concentration was 877 pmol/L (0-670). A subsequent CT of the adrenals showed a 1.2 cm left adrenal nodule. He was not suitable for adrenal vein sampling (AVS) at this time due to difficult-to-control hypertension. Biochemistry was difficult to interpret in the context of a multitude of interfering medications, which were necessary given his difficult-to-control hypertension and hypokalaemia. Once suitable, his initial AVS was unsuccessful due to failure to cannulate the right adrenal vein. He was given the further options of repeat AVS vs 11C-metomidate PET vs medical management of his blood pressure. He proceeded with a repeat AVS, with successful cannulation of both adrenal veins. This showed evidence of hyperaldosteronism on the left side, with a lateralisation index of 39.5 and a contralateral suppression index of 0.28. He proceeded with a robotic left adrenalectomy, leading to significant improvement in his blood pressure, dropping from a mean reading of 142/85 during daytime and 150/88 mmHg at nighttime on five antihypertensive agents to normotensive levels of 114/77 mmHg on two agents.
It is important to consider a broad differential for uncontrolled hypertension. It must be considered that patients can present with multiple, isolated endocrinopathies. There are diagnostic challenges with primary aldosteronism, with medication regimens regularly effecting suitability of testing and interpretation of results. AVS can be a challenging procedure, leading to diagnostic challenges in the lateralisation of primary aldosteronism; however, it or another form of lateralisation is essential to guide management options.
我们描述了一例42岁男性患者,该患者因垂体依赖性库欣病接受经蝶窦手术(TSS)5年后,最初表现为恶性高血压。尽管TSS术后其血压最初有所改善,但随访发现他仍持续高血压,尽管没有高皮质醇血症复发的临床或生化证据。尽管使用了五种抗高血压药物,他的血压仍居高不下。他的肾素浓度<5 mIU/L(9 - 103.5),醛固酮浓度为877 pmol/L(0 - 670)。随后的肾上腺CT显示左肾上腺有一个1.2 cm的结节。由于高血压难以控制,他此时不适合进行肾上腺静脉采样(AVS)。鉴于他难以控制的高血压和低钾血症,需要多种干扰药物,这使得生化指标难以解读。一旦条件合适,他的首次AVS因未能成功插管右肾上腺静脉而失败。他有重复AVS、11C-美托咪酯PET或血压药物治疗等进一步选择。他进行了重复AVS,成功插管双侧肾上腺静脉。结果显示左侧有醛固酮增多症的证据,侧化指数为39.5,对侧抑制指数为0.28。他接受了机器人辅助左肾上腺切除术,血压显著改善,从使用五种抗高血压药物时白天平均读数142/85、夜间150/88 mmHg降至使用两种药物时的正常血压水平114/77 mmHg。
对于难以控制的高血压,考虑广泛的鉴别诊断很重要。必须考虑到患者可能同时存在多种孤立的内分泌疾病。原发性醛固酮增多症存在诊断挑战,药物治疗方案经常影响检测的适用性和结果的解读。AVS可能是一个具有挑战性的操作,会给原发性醛固酮增多症的侧化带来诊断挑战;然而,它或其他形式的侧化对于指导治疗选择至关重要。